INTRODUCTION
Dengue is widespread throughout tropical and subtropical areas, including the Carribean basin and the French West Indies (Guadeloupe and Martinique). There are four types of dengue arboviruses which are, as a general rule, transmitted from man to man by mosquitoes of the genius Aedes. A first infection with any serotype (primary infection) confers durable immunity against this type, but not against the others (thus, secondary dengue remains possible). Mainly a disease of childhood, dengue fever, after an incubation period of 3 to 8 days, is characterized by acute onset of a flu-like illness, with high fever and myalgia, usually followed by a maculopapular rash. The typical course is 5 to 6 days, with a gradual recovery. Asymptomatic infection is common. 1 ± 3 Severe forms of dengue include dengue hemorragic fever and dengue shock syndrome. Dengue hemorragic fever is characterized by high fever, hemorragic manifestations (ranging from mild petechiaes to severe bleedings), thrombocytopenia, and hemoconcentration (more than 20% increase in hematocrit). 3 Some cases of dengue hemorrhagic fever evolve into shock when the above symptoms are complicated by hypotension. 3 Acording to most authors, dengue hemorragic fever is attributed to the phenomenon of``immune enhancement''. It occurs usually during second dengue infections in patients with pre-existing active or maternally acquired immunity. Heterotopic antibodies from a previous dengue virus infection actually promote viral replication within monocyte±macrophages. 1 Even in endemic areas, however, transmission from mother to fetus has rarely been reported. We describe two laboratory-confirmed cases of vertical transmission of dengue.
CASE REPORTS Case 1
A 27-year-old woman was hospitalized at 33 weeks' gestational age in premature labor. Her male infant was born by spontaneous vaginal delivery, weighing 2000 g, and had Apgar scores of 8 at 1 and 5 minutes.
She developed fever, beginning 10 hours after delivery, which persisted for 4 days, acoompanied by headache. The identification of specific immunoglobulin M (IgM), by antibody capture enzymelinked immunosorbent assay, in the absence of specific IgG confirmed primary dengue.
At birth, the neonate appeared well and had a normal complete blood count with 191Â10 9 platelets/l. He was not breastfed. On day 9, thrombocytopenia (95Â10 9 /l) and leukopenia (3.4Â10 9 /l) were observed. A viral process was then considered more likely than a bacterial infection. The infant was closely observed without receiving antibiotics. On day 11, fever to 388C developed, along with mild diarrhoea. Complete blood count revealed severe thrombocytopenia (15Â10 9 platelets/l) but normal white cell count (7.5Â10 9 leukocytes/l) with 30% neutrophils. Cerebrospinal fluid was normal. On day 13, the fever resolved, and thrombocytopenia normalized by day 15 (164Â10 9 platelets/l) without any specific treatment such as platelet transfusion. Throughout the infant's course, no hemorragic or hypotensive events were observed. Liver size, hepatic enzymes, and C-reactive protein remained within normal limits. The hematocrit ranged from 46.1% to 53%.
On day 13, dengue specific IgM antibodies were identified by IgM antibody capture enzyme-linked immunosorbent assay, as viral isolation and polymerase chain reaction could not be used at this late stage of the illness.
The infant recovered without any complication.
Dengue is commonly observed in most tropical countries, but its transmission from mother to fetus has not been frequently described. We report two such cases. The first signs of dengue in the infants appeared on the 3rd and 9th days of life. In both, a bacterial infection was suspected initially. In areas where it is endemic, the diagnosis of dengue should be considered in the neonate with signs of bacterial infection. When dengue is suspected in a pregnant woman, laboratory investigation and extended observation of the newborn are advised. Case Report
Case 2
A 31-year-old woman, gravida 3 para 1, became febrile to 408C in her 38 weeks' gestation. She also experienced chills, weakness, anorexia, headache, marked retro-orbital pain, backache, arthralgias, and vomiting. Two days later, because of the persistent fever (388C) and the infant's breech presentation, a cesarean section was performed.Difficulty was encountered in achieving homeostasis. She was found to have a low platelet count (102Â10 9 /l) which evolved to frank thrombocytopenia (with a low of 38Â10 9 platelets/l). The haematocrit ranged from 24.3% to 33%. A serologic diagnosis of secondary dengue was proven by isolation of both IgG and IgM antibodies.
Her male infant weighed 3310 g and was healthy, with 1-and 5-minute Apgar scores of 10. His first complete blood count was normal, with 288Â10 9 platelets/l. He was not bottlefed during his first days of life.
On day 3 of life, he experienced fever to 38.48C and irritability. Purpuric lesions were observed on the legs, upper chest, and face without hepatomegaly. The complete blood count showed 4,0Â10 9 leukocytes/l (64% neutrophils) and 271Â10 9 platelets/l. Cerebrospinal fluid analysis and C-reactive protein were normal. Since bacterial infection was suspected, the neonate was treated with amoxicillin and netilmicin and then referred to Pointe-a Á -Pitre University Hospital on day 4.
Ampicillin, ceftriaxone, gentamicin, and acetaminophen were administered. The fever abated on day 5, but thrombocytopenia was recognised shortly thereafter: 280Â10 9 platelets/l on day 5, 16Â10 9 /l on day 6, and the lowest platelet count, 12Â10 9 platelets/ l, on day 7. He did not receive platelet transfusion, and thrombocytopenia resolved over the ensuing 18 days. Liver enzyme levels were abnormal (maximum aspartate amino transferase: 154 UI/l on day 9). The infant's hematocrit ranged from 33.0% to 49.3%. All blood, urine, and cerebrospinal fluid cultures were negative, and all white cell differential counts and C-reactive protein measurements were normal. At no time was there liver enlargement, hypotension, or hemorrhage. After a 1-week course, the antibiotics were discontinued.
Specific IgM antibodies were identified by IgM capture enzymelinked immunosorbent assay. The child recovered uneventfully.
DISCUSSION
In both cases, the clinical picture Ð of both mother and child Ð is suggesstive of dengue, as both mothers experienced fever and nonspecific symptoms such as headache and arthragias. Thrombocytopenia was present in one mother. The children demonstrated fever, irritability, and severe thrombocytopenia. A diagnosis of bacterial infection was nevertheless pursued in both children. Published data indicate that recent infection with dengue, in both mothers and children, can be identified by detection of IgM antibodies. 2 We therefore conclude that these two neonates acquired their infection from their mothers at the end of the pregnancy.
Only three reports with a total of eight cases of prenatal transmission of symptomatic dengue exist in the literature. The fist report, in 1991, from Tahiti describes five neonates; 4 the second report is a single case report from Thailand (1994); 5 and two cases are reported by a group from Malaysia (1997). 6 Dengue was proven in five cases by serologic tests, in three by viral culture (including one with both positive viral culture and serology). Dengue in the mother was demonstrated by serology in all but one case, in which it was established on clinical findings alone. Asymptomatic dengue in the infant, after detection in the mother, is also possible: among the children of 56 infected mothers, four had positive specific IgM without symptoms. 7 The low frequency of prenatal transmission of dengue is in contrast with the high incidence of other dengue infections, estimated at 100,000,000 cases annually worldwide. 1 One explanation for its rarity may be the immunity of most women of chilbearing age to the virus serotypes in their immediate region. Vertical transmission of dengue, however, may occur quite frequently, but may not be recognised in areas where necessary laboratory equipment is lacking. In addition, subclinical infection in the newborn is also possible.
One of the neonates described above was premature, as were two cases reported in the literature. 4, 6 It has been suggested that dengue may induce preterm labor. 4 The first signs of dengue were not present at birth for seven of eight reported cases (appearing at days 2 to 6 of life), as in both of our patients (as late as day 9).
All cases in this study Ð the two mothers and their children Ð represent clear cases of uncomplicated dengue fever, according to the World Health Organization 3 criteria. Thrombocytopenia in both of the present cases resolved spontaneously, without platelet replacement, as occured in most published cases. In those reports, all patients presented with thrombocytopenia and only two received transfusions of platelets, 6 without clear beneficial effects on the clinical course. 4 ± 6 One neonate had bleeding from venipuncture sites and from the gastrointestinal tract, developed massive intracerebral haemorrhage, and died. 6 Dengue shock syndrome has been reported in neonates, in three of eight published cases, 4 although it was not seen in either of our patients. Elevation of liver enzymes levels and leukopenia are also common signs in patients of all ages. 1 The management of dengue fever and its more severe forms is supportive: adequate fluid intake, antipyretics, analgesics, regular clinical and laboratory monitoring. Fluid expansion, replacement of coagulation factors, blood and platelet transfusions may be required. Corticosteroids are of no benefit. 1 The neonates previously reported did not receive any other specific therapy. 4 ± 6 When a pregnant or parturient woman develops signs consistent with dengue, we advocate that this diagnosis be considered in her child, even if the newborn appears well in the first several days of life. In areas where dengue is endemic (particularly during the rainy season) or during epidemics, we suggest that neonatal dengue be considered wherever bacterial infections is suspected. When dengue is
